Horizon Pharma (HZNP) PT Raised to $40 and Highlighted as Top Pick at BMO Capital After TED AdComm
Tweet Send to a Friend
BMO Capital analyst Gary Nachman raised the price target on Horizon Pharma (NASDAQ: HZNP) to $40.00 (from $36.00) after Friday's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
